Insider Trading & Ownership - Dhingra Kapil

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Dhingra Kapil
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-07
Sale
2020-12-09
7:48 pm
Replimune Group Inc. REPL Dhingra Kapil
Director
40,000 $45.56 $1,822,395 3,169
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-04-01
Option Award
2025-04-03
8:03 pm
N/A
2035-04-01
Replimune Group Inc. REPL Dhingra Kapil
Director
32,000 $0 32,000
(Direct)
View
2025-02-13
Option Award
2025-02-18
8:15 pm
N/A
2035-02-12
LAVA Therapeutics NV LVTX Dhingra Kapil
Director
33,390 $0 33,390
(Direct)
View

Ownership
2025-01-02
09:26 am
N/A
N/A
LAVA Therapeutics NV LVTX Dhingra Kapil
Director
0 $0 311,130
(Direct)
View
2024-06-06
Option Award
2024-06-06
5:50 pm
N/A
2034-06-05
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
30,550 $0 30,550
(Direct)
View
2024-06-04
Option Award
2024-06-06
4:31 pm
N/A
2034-06-03
CARGO Therapeutics Inc. CRGX Dhingra Kapil
Director
11,871 $0 11,871
(Direct)
View
2024-04-15
Option Award
2024-04-17
4:15 pm
N/A
2034-04-14
CARGO Therapeutics Inc. CRGX Dhingra Kapil
Director
49,265 $0 49,265
(Direct)
View
2024-04-01
Option Award
2024-04-03
8:01 pm
N/A
2034-04-01
Replimune Group Inc. REPL Dhingra Kapil
Director
32,000 $0 32,000
(Direct)
View
2023-05-16
Option Award
2023-05-17
9:06 pm
N/A
2033-05-15
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
16,500 $0 16,500
(Direct)
View
2023-04-01
Option Award
2023-04-04
8:03 pm
N/A
2033-04-01
Replimune Group Inc. REPL Dhingra Kapil
Director
25,200 $0 25,200
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:05 pm
N/A
2032-06-09
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
15,000 $0 15,000
(Direct)
View
2022-04-01
Option Award
2022-04-05
4:12 pm
N/A
2032-04-01
Replimune Group Inc. REPL Dhingra Kapil
Director
16,500 $0 16,500
(Direct)
View
2021-06-18
Option Award
2021-06-22
6:13 pm
N/A
2031-06-17
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
15,000 $0 15,000
(Direct)
View
2021-04-01
Option Award
2021-04-05
8:11 pm
N/A
2031-04-01
Replimune Group Inc. REPL Dhingra Kapil
Director
16,500 $0 16,500
(Direct)
View
2021-01-19
Option Award
2021-01-22
4:59 pm
N/A
2031-01-19
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
29,842 $0 29,842
(Direct)
View

Ownership
2021-01-22
4:53 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Dhingra Kapil
Director
0 $0 69,353
(Direct)
View
2020-12-07
Exercise
2020-12-09
7:48 pm
N/A
2026-01-21
Replimune Group Inc. REPL Dhingra Kapil
Director
40,000 $0 3,169
(Direct)
View
2020-12-07
Exercise
2020-12-09
7:48 pm
N/A
N/A
Replimune Group Inc. REPL Dhingra Kapil
Director
40,000 $1.75 3,169
(Direct)
View
2020-05-14
Option Award
2020-05-15
5:46 pm
N/A
2030-05-13
FIVE PRIME THERAPEUTICS INC. FPRX Dhingra Kapil
Director
20,000 $0 20,000
(Direct)
View